Photo: Dr. Victoria Kirsh, OHS Scientific Associate. Photo Credit: Greg Sigurdson At a hybrid event presented live and via webinar on May 30, 2023, OHS Scientific Associate Dr. Victoria Kirsh provided an update on CanPath’s national COVID-19 Antibody Study. Using real-world data from the SUrveying Prospective Population cOhorts for COVID-19 pRevalence and ouTcomes in Canada
Archives: Research Underway
Nicholas Cheng is using data to compare over 400 OHS participants who’ve experienced a cancer diagnosis, with matched cancer-free participants, to look for biomarkers in the blood that could be used to detect breast, prostate and pancreatic cancers several years before a traditional diagnosis. Hear what motivates this PHD student, as he reflects on his
A new funding opportunity from the CIHR Institute of Cancer Research (CIHR-ICR) is available and provides up to $500,000 to use provincial data from the OHS, or to use pan-Canadian data from the Canadian Partnership for Tomorrow’s Health (CanPath). Up to $100,000 over one year will be awarded for a single grant. The goal of